Expert Interview

Chronic Kidney Disease in People with Type 2 Diabetes

Author and Disclosure Information

 

It is important to consider where the patient is along the disease spectrum, and to educate them on the benefits of taking a proactive approach to their health. Don’t wait for diabetes to develop before doing something about it. We have to take action earlier, and more definitively.

We do everything we can to help patients with the high cost of diabetes medications. Pharma companies offer various coupons and patient assistance programs, but it's really important that we get people on the right therapy. In order for that to happen, they have to come to office visits and get lab tests done.

Is there anything else you would like to share on this topic?

Dr. McGill: Once a person has been diagnosed with diabetes, then excellent glucose control from the onset has been shown to prevent later complications, and early treatment is inexpensive. As people progress through their journey with diabetes and blood sugars go up, we have excellent therapies that help manage high glucose and help with weight loss.

We have to be realistic and rethink our approach in some ways, but as long as people develop good health care habits and visit the doctor once or twice a year specifically to address diabetes and blood pressure, we might be able to avoid long-term complications.

Pages

Recommended Reading

Strong link found between enterovirus and type 1 diabetes
MDedge Endocrinology
Balanced fat intake links with less type 2 diabetes
MDedge Endocrinology
Food insecurity a growing problem for many with CVD
MDedge Endocrinology
Newer drugs not cost effective for first-line diabetes therapy
MDedge Endocrinology
3-D scaffold could revolutionize diabetes treatment
MDedge Endocrinology
Bariatric surgery prompts visceral fat reduction, cardiac changes
MDedge Endocrinology
Dapagliflozin DELIVERs regardless of systolic pressure in HFpEF
MDedge Endocrinology
New advice on artificial pancreas insulin delivery systems 
MDedge Endocrinology
Older diabetes drugs linked to dementia risk -- one lower, one higher
MDedge Endocrinology
Tirzepatide’s benefits expand: Lean mass up, serum lipids down
MDedge Endocrinology